Načítá se...
Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity
[Image: see text] Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) is a deubiquitylating enzyme that is proposed as a potential therapeutic target in neurodegeneration, cancer, and liver and lung fibrosis. Herein we report the discovery of the most potent and selective UCHL1 probe (IMP-1710) to date...
Uloženo v:
| Vydáno v: | J Am Chem Soc |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical
Society
2020
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7366380/ https://ncbi.nlm.nih.gov/pubmed/32579346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jacs.0c04527 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|